ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
19.95
-0.34 (-1.68%)
Feb 21, 2025, 4:00 PM EST - Market closed
ACADIA Pharmaceuticals Employees
As of December 31, 2023, ACADIA Pharmaceuticals had 598 total employees, including 597 full-time and 1 part-time employees. The number of employees increased by 85 or 16.57% compared to the previous year.
Employees
598
Change (1Y)
85
Growth (1Y)
16.57%
Revenue / Employee
$1,553,906
Profits / Employee
$214,893
Market Cap
3.32B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ACAD News
- 8 days ago - Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 10 days ago - Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Business Wire
- 5 weeks ago - Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 5 weeks ago - Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome - Business Wire
- 2 months ago - Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 - Business Wire
- 2 months ago - Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million - Business Wire
- 2 months ago - Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer - Business Wire
- 3 months ago - Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET - Seeking Alpha